98% SVR12 in Korean and Taiwanese patients with chronic genotype 2 HCV infection receiving 12 weeks of sofosbuvir plus ribavirin: Results from an international, multicenter phase 3 study

Authors
Category Primary study
JournalJournal of Hepatology
Year 2015
This article has no abstract
Epistemonikos ID: 5180e14e7c195555f6b73fca9b8401424e09b1ad
First added on: Feb 07, 2025